Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Positron Emission Tomography/Computed Tomography and Lymphovascular Invasion Predict Recurrence in Stage I Lung Cancers

Positron Emission Tomography/Computed Tomography and Lymphovascular Invasion Predict Recurrence... ORIGINAL ARTICLE Positron Emission Tomography/Computed Tomography and Lymphovascular Invasion Predict Recurrence in Stage I Lung Cancers Satoshi Shiono, MD, PhD, Masami Abiko, MD, PhD, and Toru Sato, MD, PhD -18 Fluorodeoxyglucose (FDG) positron emission tomog- Background: Although pathologic stage I lung cancers generally Fraphy (PET) has become an important tool in staging have a favorable prognosis, approximately 20% of patients experi- patients with non-small cell lung cancer (NSCLC). Recent ence recurrence after surgery. Therefore, a method of selecting studies have shown that the rate of FDG uptake by the patients who need adjuvant therapy is necessary. The goal of this primary NSCLC site correlated with tumor aggressiveness study was to evaluate the significance of positron emission tomog- and that the standardized uptake value (SUV) was a signifi- raphy (PET)/computed tomography (CT) results after lung cancer cant prognostic factor in surgically resected patients with surgery and to identify the predictive factors for recurrence in cases 2–9 lung cancer, even in early-stage bronchioloalveolar carci- 10,11 of pathologic stage I lung cancer. noma. The FDG SUV may be a powerful surrogate Methods: From January 2004 to December 2008, 356 patients with marker for outcome in NSCLC. Nevertheless, it remains lung cancer underwent http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

Positron Emission Tomography/Computed Tomography and Lymphovascular Invasion Predict Recurrence in Stage I Lung Cancers

Sato, Toru
Journal of Thoracic Oncology , Volume 6 (1) – Jan 1, 2011
Download PDF
5 pages

Loading next page...
 
/lp/wolters-kluwer-health/positron-emission-tomography-computed-tomography-and-lymphovascular-kohE1fY8KX

References (26)

ISSN
1556-0864
DOI
10.1097/JTO.0b013e3181f9abca
pmid
21079522
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL ARTICLE Positron Emission Tomography/Computed Tomography and Lymphovascular Invasion Predict Recurrence in Stage I Lung Cancers Satoshi Shiono, MD, PhD, Masami Abiko, MD, PhD, and Toru Sato, MD, PhD -18 Fluorodeoxyglucose (FDG) positron emission tomog- Background: Although pathologic stage I lung cancers generally Fraphy (PET) has become an important tool in staging have a favorable prognosis, approximately 20% of patients experi- patients with non-small cell lung cancer (NSCLC). Recent ence recurrence after surgery. Therefore, a method of selecting studies have shown that the rate of FDG uptake by the patients who need adjuvant therapy is necessary. The goal of this primary NSCLC site correlated with tumor aggressiveness study was to evaluate the significance of positron emission tomog- and that the standardized uptake value (SUV) was a signifi- raphy (PET)/computed tomography (CT) results after lung cancer cant prognostic factor in surgically resected patients with surgery and to identify the predictive factors for recurrence in cases 2–9 lung cancer, even in early-stage bronchioloalveolar carci- 10,11 of pathologic stage I lung cancer. noma. The FDG SUV may be a powerful surrogate Methods: From January 2004 to December 2008, 356 patients with marker for outcome in NSCLC. Nevertheless, it remains lung cancer underwent

Journal

Journal of Thoracic Oncology – Wolters Kluwer Health

Published: Jan 1, 2011

There are no references for this article.